谷歌浏览器插件
订阅小程序
在清言上使用

ANMCO Position Paper on Antithrombotic Treatment of Patients with Atrial Fibrillation Undergoing Intracoronary Stenting And/or Acute Coronary Syndromes

EUROPEAN HEART JOURNAL SUPPLEMENTS(2022)

引用 2|浏览11
暂无评分
摘要
Patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) with or without acute coronary syndromes (ACS) represent a subgroup with a challenging pharmacological management. Indeed, if on the one hand antithrombotic therapy should reduce the risk related to recurrent ischemic events and/or stent thrombosis, on the other hand care should be taken to avoid major bleeding events. In recent years, several trials, which overall included more than 12 000 patients, have been conducted demonstrating the safety of different therapeutic combinations of oral antiplatelet and anticoagulant agents. In the present ANMCO position paper we propose a decision-making algorithm on antithrombotic strategies based on scientific evidence and expert consensus to be adopted in the periprocedural phase, at the time of hospital discharge and in the long-term follow-up of patients with AF undergoing PCI with/without ACS.
更多
查看译文
关键词
Anticoagulant Therapy,Atrial Fibrillation
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要